Growth Metrics

Amdocs (DOX) Cash & Equivalents (2016 - 2025)

Amdocs (DOX) has 17 years of Cash & Equivalents data on record, last reported at $325.0 million in Q3 2025.

  • On a quarterly basis, Cash & Equivalents fell 6.09% to $325.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $325.0 million, a 6.09% decrease, with the full-year FY2025 number at $325.0 million, down 6.09% from a year prior.
  • Cash & Equivalents reached $325.0 million in Q3 2025 per DOX's latest filing, down from $346.1 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for DOX hit a ceiling of $709.1 million in Q3 2021 and a floor of $325.0 million in Q3 2025.
  • A 5-year average of $494.7 million and a median of $520.1 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: tumbled 33.46% in 2024, then decreased 6.09% in 2025.
  • Tracing DOX's Cash & Equivalents over 5 years: stood at $709.1 million in 2021, then dropped by 19.14% to $573.4 million in 2022, then decreased by 9.3% to $520.1 million in 2023, then crashed by 33.46% to $346.1 million in 2024, then fell by 6.09% to $325.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for DOX at $325.0 million in Q3 2025, $346.1 million in Q3 2024, and $520.1 million in Q3 2023.